Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death

被引:14
|
作者
Martinez, Katherine A. [1 ]
Bos, J. Martijn [1 ,2 ,3 ]
Baggish, Aaron L. [4 ,5 ]
Phelan, Dermot M. [6 ]
Tobert, Kathryn E. [1 ]
Newman, Darrel B. [2 ]
Scherer, Erica [6 ]
Petek, Bradley J. [4 ,7 ]
Ackerman, Michael J. [1 ,2 ,3 ,9 ]
Martinez, Matthew W. [8 ]
机构
[1] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA
[2] Mayo Clin, Dept Cardiovasc Med, Div Heart Rhythm Serv, Windland Smith Rice Genet Heart Rhythm Clin, Rochester, MN USA
[3] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Rochester, MN USA
[4] Massachusetts Gen Hosp, Cardiovasc Performance Program, Boston, MA USA
[5] Univ Lausanne, Inst Sport Sci, Dept Cardiol, Lausanne, Switzerland
[6] Atrium Hlth, Sanger Heart & Vasc Inst, Charlotte, NC USA
[7] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR USA
[8] Morristown Med Ctr, Morristown, NJ USA
[9] Mayo Clin, Mayo Clin Windland Smith Rice Genet Heart Rhythm C, Windland Smith Rice Sudden Death Genom Lab, Guggenheim 501, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
ARVC; athletes; exercise; HCM; LQTS; sudden death; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; LONG QT SYNDROME; TASK-FORCE; HYPERTROPHIC CARDIOMYOPATHY; DISQUALIFICATION RECOMMENDATIONS; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; ASSOCIATION; EXERCISE; SPORTS;
D O I
10.1016/j.jacc.2023.05.059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND People diagnosed with genetic heart diseases (GHDs) associated with sudden cardiac death (SCD) have historically been restricted from competitive sports. Recent data documenting return-to-play (RTP) experiences following shared decision making (SDM) suggest that cardiac event rates for athletes with a GHD are lower than previously described, thereby suggesting an opportunity to reconsider this paradigm.OBJECTIVES The purpose of this study was to evaluate clinical outcomes among National Collegiate Athletic Association Division I university and professional athletes diagnosed with a GHD. METHODS A multicenter retrospective analysis was performed to examine demographics, clinical characteristics, RTP outcomes, and cardiac events among elite athletes with a GHD.RESULTS A total of 76 elite (66%, Division I, 34% professional) athletes (age 19.9 & PLUSMN; 5 years, 28% women) diagnosed with a GHD (hypertrophic cardiomyopathy [53%], long QT syndrome, long QT syndrome [26%]) comprise this cohort. Most athletes were asymptomatic (48 of 76, 63%) before diagnosis and had their GHD detected during routine pre-participation cardiovascular screening. Most athletes (55 of 76, 72%) were initially disqualified from their sport but subsequently opted for unrestricted RTP after comprehensive clinical evaluation and SDM. To date, (mean follow-up 7 & PLUSMN; 6 years), only 1 exercise-related (1.3%) and 2 nonexercise-related GHD-associated adverse cardiac events occurred. There have been no fatalities during follow-up. CONCLUSIONS This is the first study describing the experience of athletes with a known SCD-predisposing GHD who are competing at the elite level. After careful evaluation, risk stratification, and tailoring of their GHD therapy, RTP following SDM appears associated with low, nonfatal events rates at elite levels of sport. (J Am Coll Cardiol 2023;82:661-670) & COPY; 2023 by the American College of Cardiology Foundation.
引用
收藏
页码:661 / 670
页数:10
相关论文
共 50 条
  • [1] Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death
    Tobert, Kathryn E.
    Bos, J. Martijn
    Garmany, Ramin
    Ackerman, Michael J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (06) : 594 - 604
  • [2] Return-to-Play for Athletes With Genetic Heart Diseases
    Turkowski, Kari L.
    Bos, J. Martijn
    Ackerman, Nicholas C.
    Rohatgi, Ram K.
    Ackerman, Michael J.
    [J]. CIRCULATION, 2018, 137 (10) : 1086 - 1088
  • [3] Return-to-Play Decisions in Athletes with Cardiac Conditions
    Lawless, Christine E.
    [J]. PHYSICIAN AND SPORTSMEDICINE, 2009, 37 (01): : 80 - 91
  • [4] Return-to-Play Considerations After COVID-19 Infection in Elite Athletes
    Ross, Ryan
    Irvin, Laura
    Severin, Richard
    Ellis, Brian
    [J]. JOURNAL OF ATHLETIC TRAINING, 2021, 56 (10) : 1061 - 1063
  • [5] Making Prudent Recommendations for Return-to-Play in Adult Athletes With Cardiac Conditions
    Oliveira, Leonardo P. J.
    Lawless, Christine E.
    [J]. CURRENT SPORTS MEDICINE REPORTS, 2011, 10 (02) : 65 - 77
  • [6] SUDDEN CARDIAC DEATH AND THE ATHLETES HEART
    WIGHT, JN
    SALEM, D
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (14) : 1473 - 1480
  • [7] Return-to-Play Outcomes in Elite Athletes After Cervical Spine Surgery: A Systematic Review
    Leider, Joseph
    Piche, Joshua David
    Khan, Moin
    Aleem, Ilyas
    [J]. SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2021, 13 (05): : 437 - 445
  • [8] Sudden Cardiac Death in Genetic Heart Diseases and the Promise of Prevention
    Maron, Barry J.
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (03): : 257 - 260
  • [9] Heart rate variability in concussed varsity athletes: From injury to return-to-play
    Senthinathan, Arrani
    Mainwaring, Lynda
    [J]. BRAIN INJURY, 2014, 28 (5-6) : 745 - 745
  • [10] Prevalence of Suicide Among Patients With Sudden Death-Predisposing Genetic Heart Diseases
    Niaz, Talha
    Saunders, Michaela
    Bos, J. Martijn
    Campbell, Robert M.
    Ackerman, Michael J.
    [J]. JACC-CLINICAL ELECTROPHYSIOLOGY, 2021, 7 (02) : 253 - 255